#United States #Alpharetta #ADHD Awareness #Relexxii #Vertical Pharmaceuticals

October is ADHD Awareness Month

As we dive into October, a special spotlight is being shone on Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month. This period not only raises awareness about the disorder but also underscores the essentiality of timely diagnosis and individualized treatment. Vertical Pharmaceuticals is dedicated to supporting the ADHD community, emphasizing the critical role of personalized care in managing this condition.

Understanding ADHD

ADHD affects approximately 11.7% of children and adolescents in the U.S., with adult diagnoses estimated at around 6%. Despite this significant prevalence, numerous misconceptions persist, particularly regarding how ADHD manifests in women. Often, their symptoms can be less apparent and easily missed. Typical symptoms include a consistent pattern of inattention, hyperactivity, and impulsivity, all of which can disrupt daily functioning and hinder quality of life.

Clinically, ADHD presents distinctively in each individual, making it vital to find the right treatment and dosing for effective symptom control. The optimization of methylphenidate (one of the main components in RELEXXII®) has shown promising results in symptom management, especially for children. This highlights the importance of continuous medication management and the need for varied tablet strengths to accommodate diverse patient needs.

Commitment to Innovation

Art Deas, CEO of Alora Pharmaceuticals, Vertical Pharmaceuticals' parent company, emphasizes their commitment to enhancing the lives of patients: “Alora is driven by a commitment to innovation and patient well-being. We take pride in advancing therapies that genuinely impact daily life. RELEXXII® offers healthcare providers the flexibility to tailor treatment precisely, catering to the unique requirements of individuals affected by ADHD.”

If you or someone you care for is facing ADHD symptoms, it’s crucial to engage with a healthcare provider for a dialogue about treatment options. Partnering with healthcare professionals who spearhead the diagnosis and treatment process can lead to more effective, individualized care through precision dosing.

Resources for Support

For those seeking additional information and support concerning ADHD, Vertical Pharmaceuticals encourages exploration of reliable resources. Notable organizations offering assistance include:

• - ADDitude Magazine
• - American Academy of Child and Adolescent Psychiatry
• - American Professional Society of ADHD and Related Disorders
• - Children and Adults with Attention-Deficit Hyperactivity Disorder
• - National Institute of Mental Health
• - The Attention Deficit Disorder Association

These organizations provide valuable insights and support not just for patients but also for caregivers navigating the complexities of ADHD.

About Vertical Pharmaceuticals

Vertical Pharmaceuticals, part of Alora Pharmaceuticals, is based in Alpharetta, GA. The company prioritizes quality, reliability, and affordability in its drug offerings. As a collective family of companies, Alora employs over 550 individuals across multiple facilities in Texas and Georgia, reaffirming its commitment to producing medicines domestically. With an impressive portfolio, Alora Pharmaceuticals stands at the forefront of ensuring patient access to effective and affordable treatments.

For more detailed information about RELEXXII®, please visit relexxii.com. Additionally, for important safety information and full prescribing information, visit relexxii.com/isi and relexxii.com/pi respectively. These resources are for U.S. residents only.